Antonio R. Pera is Director at ANI PHARMACEUTICALS INC (ANIP). They have made 4 open-market trades across 1 company since 2021, most recently 2026-05-21.
CIK 0001689325
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $127K since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2025-09-03 | 2025-09-04 | $94.94 | $1.4M | +2.0% | -3.8% | -13.6% |
| ANIP | SELL | 2025-08-20 | 2025-08-20 | $89.73 | $973K | +3.9% | +6.8% | -10.5% |
| ANIP | SELL | 2024-03-04 | 2024-03-06 | $65.20 | $456K | +1.6% | +1.6% | -2.7% |
| ANIP | SELL · 10b5-1 | 2023-08-14 | 2023-08-15 | $60.37 | $181K | +3.6% | +3.2% | -16.2% |
| ANIP | BUY | 2021-12-07 | 2021-12-09 | $42.26 | $127K | +9.6% | -0.7% | -14.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.